vs
FirstCash Holdings, Inc.（FCFS）とLantheus Holdings, Inc.（LNTH）の財務データ比較。上の社名をクリックして会社を切り替えられます
FirstCash Holdings, Inc.の直近四半期売上が大きい（$501.3M vs $406.8M、Lantheus Holdings, Inc.の約1.2倍）。FirstCash Holdings, Inc.の純利益率が高く（20.8% vs 13.3%、差は7.5%）。FirstCash Holdings, Inc.の前年同期比売上増加率が高い（21.2% vs 4.0%）。過去8四半期でFirstCash Holdings, Inc.の売上複合成長率が高い（16.9% vs 4.9%）
FirstCash Holdings, Inc.は米国テキサス州フォートワースに本社を置く質屋事業を営む企業で、米国国内及びラテンアメリカ各地で小売型質店を展開しています。ナスダック証券取引所に上場しており、南北アメリカ全域に広範な事業基盤を有しています。
ランティウス・ホールディングスはグローバルな医療企業で、革新的な診断用造影剤や関連ソリューションの開発・製造・販売を事業の核としています。製品は腫瘍学、循環器学、泌尿器学などの分野に対応し、北米を中心に世界の主要市場で事業を展開しています。
FCFS vs LNTH — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $501.3M | $406.8M |
| 純利益 | $104.2M | $54.1M |
| 粗利率 | — | 59.2% |
| 営業利益率 | 28.5% | 19.0% |
| 純利益率 | 20.8% | 13.3% |
| 売上前年比 | 21.2% | 4.0% |
| 純利益前年比 | 24.7% | 558.8% |
| EPS（希薄化後） | $2.35 | $0.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $501.3M | $406.8M | ||
| Q3 25 | $411.0M | $384.0M | ||
| Q2 25 | $385.1M | $378.0M | ||
| Q1 25 | $371.1M | $372.8M | ||
| Q4 24 | $413.7M | $391.1M | ||
| Q3 24 | $363.1M | $378.7M | ||
| Q2 24 | $363.5M | $394.1M | ||
| Q1 24 | $366.8M | $370.0M |
| Q4 25 | $104.2M | $54.1M | ||
| Q3 25 | $82.8M | $27.8M | ||
| Q2 25 | $59.8M | $78.8M | ||
| Q1 25 | $83.6M | $72.9M | ||
| Q4 24 | $83.5M | $-11.8M | ||
| Q3 24 | $64.8M | $131.1M | ||
| Q2 24 | $49.1M | $62.1M | ||
| Q1 24 | $61.4M | $131.1M |
| Q4 25 | — | 59.2% | ||
| Q3 25 | — | 57.9% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 63.5% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 65.4% |
| Q4 25 | 28.5% | 19.0% | ||
| Q3 25 | 27.4% | 11.4% | ||
| Q2 25 | 21.1% | 23.3% | ||
| Q1 25 | 30.0% | 27.4% | ||
| Q4 24 | 26.5% | 29.1% | ||
| Q3 24 | 23.5% | 35.3% | ||
| Q2 24 | 18.2% | 26.1% | ||
| Q1 24 | 22.3% | 28.8% |
| Q4 25 | 20.8% | 13.3% | ||
| Q3 25 | 20.1% | 7.2% | ||
| Q2 25 | 15.5% | 20.8% | ||
| Q1 25 | 22.5% | 19.6% | ||
| Q4 24 | 20.2% | -3.0% | ||
| Q3 24 | 17.9% | 34.6% | ||
| Q2 24 | 13.5% | 15.8% | ||
| Q1 24 | 16.7% | 35.4% |
| Q4 25 | $2.35 | $0.86 | ||
| Q3 25 | $1.86 | $0.41 | ||
| Q2 25 | $1.34 | $1.12 | ||
| Q1 25 | $1.87 | $1.02 | ||
| Q4 24 | $1.86 | $-0.18 | ||
| Q3 24 | $1.44 | $1.79 | ||
| Q2 24 | $1.08 | $0.88 | ||
| Q1 24 | $1.35 | $1.87 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $125.2M | $359.1M |
| 総負債低いほど良い | $2.2B | $568.7M |
| 株主資本純資産 | $2.3B | $1.1B |
| 総資産 | $5.3B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.98× | 0.52× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $125.2M | $359.1M | ||
| Q3 25 | $130.2M | $382.0M | ||
| Q2 25 | $101.5M | $695.6M | ||
| Q1 25 | $146.0M | $938.5M | ||
| Q4 24 | $175.1M | $912.8M | ||
| Q3 24 | $106.3M | $866.4M | ||
| Q2 24 | $113.7M | $757.0M | ||
| Q1 24 | $135.1M | $718.3M |
| Q4 25 | $2.2B | $568.7M | ||
| Q3 25 | $2.2B | $567.9M | ||
| Q2 25 | $1.7B | $566.8M | ||
| Q1 25 | $1.7B | $566.1M | ||
| Q4 24 | $1.7B | $565.3M | ||
| Q3 24 | $1.7B | $613.0K | ||
| Q2 24 | $1.7B | $563.2M | ||
| Q1 24 | $1.5B | $562.5M |
| Q4 25 | $2.3B | $1.1B | ||
| Q3 25 | $2.2B | $1.1B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.1B | $1.2B | ||
| Q4 24 | $2.1B | $1.1B | ||
| Q3 24 | $2.0B | $1.2B | ||
| Q2 24 | $2.0B | $1.0B | ||
| Q1 24 | $2.0B | $945.5M |
| Q4 25 | $5.3B | $2.2B | ||
| Q3 25 | $5.2B | $2.3B | ||
| Q2 25 | $4.5B | $2.1B | ||
| Q1 25 | $4.4B | $2.1B | ||
| Q4 24 | $4.5B | $2.0B | ||
| Q3 24 | $4.4B | $2.0B | ||
| Q2 24 | $4.3B | $1.9B | ||
| Q1 24 | $4.2B | $1.8B |
| Q4 25 | 0.98× | 0.52× | ||
| Q3 25 | 1.01× | 0.51× | ||
| Q2 25 | 0.79× | 0.49× | ||
| Q1 25 | 0.83× | 0.49× | ||
| Q4 24 | 0.85× | 0.52× | ||
| Q3 24 | 0.87× | 0.00× | ||
| Q2 24 | 0.85× | 0.55× | ||
| Q1 24 | 0.75× | 0.59× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $206.6M | $90.2M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $81.4M |
| FCFマージンFCF / 売上 | — | 20.0% |
| 設備投資強度設備投資 / 売上 | — | 2.2% |
| キャッシュ転換率営業CF / 純利益 | 1.98× | 1.67× |
| 直近12ヶ月FCF直近4四半期 | — | $354.1M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $206.6M | $90.2M | ||
| Q3 25 | $135.8M | $105.3M | ||
| Q2 25 | $116.9M | $87.1M | ||
| Q1 25 | $126.6M | $107.6M | ||
| Q4 24 | $198.1M | $157.7M | ||
| Q3 24 | $113.1M | $175.1M | ||
| Q2 24 | $106.2M | $84.7M | ||
| Q1 24 | $122.5M | $127.2M |
| Q4 25 | — | $81.4M | ||
| Q3 25 | — | $94.7M | ||
| Q2 25 | — | $79.1M | ||
| Q1 25 | — | $98.8M | ||
| Q4 24 | — | $141.4M | ||
| Q3 24 | — | $159.3M | ||
| Q2 24 | — | $73.5M | ||
| Q1 24 | — | $119.0M |
| Q4 25 | — | 20.0% | ||
| Q3 25 | — | 24.7% | ||
| Q2 25 | — | 20.9% | ||
| Q1 25 | — | 26.5% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 42.0% | ||
| Q2 24 | — | 18.7% | ||
| Q1 24 | — | 32.2% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 2.2% |
| Q4 25 | 1.98× | 1.67× | ||
| Q3 25 | 1.64× | 3.79× | ||
| Q2 25 | 1.95× | 1.11× | ||
| Q1 25 | 1.51× | 1.47× | ||
| Q4 24 | 2.37× | — | ||
| Q3 24 | 1.74× | 1.34× | ||
| Q2 24 | 2.16× | 1.36× | ||
| Q1 24 | 2.00× | 0.97× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
